Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32351
Title: The Who, What, When and Where of Inpatient Direct Oral Penicillin Challenge - Implications for health services implementation.
Austin Authors: Trubiano, Jason ;Vogrin, S;Mitri, Elise A ;Hall, R;Copaescu, Ana ;Waldron, J;De Luca, J;Rose, Morgan T ;Mackay, G;Lambros, B;Douglas, A P;Holmes, Natasha E ;Chua, Kyra Y L 
Affiliation: Centre for Antibiotic Allergy and Research
Infectious Diseases
Albury Wodonga Health, Albury, NSW 2640.
Pharmacy
Data Analytics Research and Evaluation (DARE) Centre
Issue Date: 5-Jul-2023
Date: 2023
Publication information: Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 2023; 77(1)
Abstract: Inpatient direct oral challenge programs are increasingly deployed as part of antimicrobial stewardship (AMS) initiatives to reduce the burden and impacts of penicillin allergy labels on antibiotic prescribing. Using data from a prospective multicentre cohort inpatient penicillin allergy program, we identify the key targets for delabeling to aid health service implementation.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32351
DOI: 10.1093/cid/ciad156
ORCID: 0000-0002-5111-6367
Journal: Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
PubMed URL: 36929823
ISSN: 1537-6591
Type: Journal Article
Subjects: amoxicillin allergy
antimicrobial stewardship
beta-lactam allergy
drug allergy
oral provocation
Appears in Collections:Journal articles

Show full item record

Page view(s)

112
checked on Apr 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.